BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25670512)

  • 1. Enabling the curation of your pharmacogenetic study.
    McDonagh Em; Whirl-Carrillo M; Altman RB; Klein TE
    Clin Pharmacol Ther; 2015 Feb; 97(2):116-9. PubMed ID: 25670512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
    Owen RP; Altman RB; Klein TE
    Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).
    Owen RP; Klein TE; Altman RB
    Clin Pharmacol Ther; 2007 Oct; 82(4):472-5. PubMed ID: 17713470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation mining experiments in the pharmacogenomics domain.
    Rinaldi F; Schneider G; Clematide S
    J Biomed Inform; 2012 Oct; 45(5):851-61. PubMed ID: 22580177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge.
    Gong L; Whirl-Carrillo M; Klein TE
    Curr Protoc; 2021 Aug; 1(8):e226. PubMed ID: 34387941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGxMine: Text mining for curation of PharmGKB.
    Lever J; Barbarino JM; Gong L; Huddart R; Sangkuhl K; Whaley R; Whirl-Carrillo M; Woon M; Klein TE; Altman RB
    Pac Symp Biocomput; 2020; 25():611-622. PubMed ID: 31797632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PharmGKB: the Pharmacogenomics Knowledge Base.
    Thorn CF; Klein TE; Altman RB
    Methods Mol Biol; 2013; 1015():311-20. PubMed ID: 23824865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.
    Relling MV; Klein TE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Caudle KE
    Clin Pharmacol Ther; 2020 Jan; 107(1):171-175. PubMed ID: 31562822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine.
    Whirl-Carrillo M; Huddart R; Gong L; Sangkuhl K; Thorn CF; Whaley R; Klein TE
    Clin Pharmacol Ther; 2021 Sep; 110(3):563-572. PubMed ID: 34216021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extraction of pharmacogenetic and pharmacogenomic relations--a case study using PharmGKB.
    Buyko E; Beisswanger E; Hahn U
    Pac Symp Biocomput; 2012; ():376-87. PubMed ID: 22174293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].
    Stingl JC; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1509-21. PubMed ID: 24170080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.
    McDonagh EM; Whirl-Carrillo M; Garten Y; Altman RB; Klein TE
    Biomark Med; 2011 Dec; 5(6):795-806. PubMed ID: 22103613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
    Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
    Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PharmGKB: understanding the effects of individual genetic variants.
    Sangkuhl K; Berlin DS; Altman RB; Klein TE
    Drug Metab Rev; 2008; 40(4):539-51. PubMed ID: 18949600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the PharmGKB knowledge base as a resource for efficiently assessing the clinical validity and utility of pharmacogenetic assays.
    Kawamoto K; Orlando LA; Voora D; Lobach DF; Joy S; Cho A; Ginsburg GS
    AMIA Annu Symp Proc; 2009 Nov; 2009():307-11. PubMed ID: 20351870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
    Thorn CF; Klein TE; Altman RB
    Methods Mol Biol; 2005; 311():179-91. PubMed ID: 16100408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary pharmacogenetic assays in view of the PharmGKB database.
    Tilleman L; Weymaere J; Heindryckx B; Deforce D; Nieuwerburgh FV
    Pharmacogenomics; 2019 Mar; 20(4):261-272. PubMed ID: 30883266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
    Hodge AE; Altman RB; Klein TE
    Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard operating procedure for curation and clinical interpretation of variants in cancer.
    Danos AM; Krysiak K; Barnell EK; Coffman AC; McMichael JF; Kiwala S; Spies NC; Sheta LM; Pema SP; Kujan L; Clark KA; Wollam AZ; Rao S; Ritter DI; Sonkin D; Raca G; Lin WH; Grisdale CJ; Kim RH; Wagner AH; Madhavan S; Griffith M; Griffith OL
    Genome Med; 2019 Nov; 11(1):76. PubMed ID: 31779674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the prediction of pharmacogenes using text-derived drug-gene relationships.
    Garten Y; Tatonetti NP; Altman RB
    Pac Symp Biocomput; 2010; ():305-14. PubMed ID: 19908383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.